Denmark· DK-28104188807
Bridion
A sugammadex product containing sugammadexnatrium, registered in Denmark by Merck Sharp & Dohme B.V.. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Sugammadex is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AB35 (sugammadex), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Sugammadex · ATC V03AB35
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Sugammadexnatrium
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Denmark (DK)
- ATC code
- V03AB35
- ATC class
- Sugammadex
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28104188807
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for sugammadex.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sugammadex · interactions on record
34 records
- 14 severe
- 20 moderate
Most severe, free to view
- IUP aus Plastik mit GestagenG02BA03severe
- Drospirenone and ethinylestradiolG03AA12severe
- NorethisteroneG03AC01severe
- LevonorgestrelG03AC03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AB35
Sugammadex, as other registers publish it.
- GermanyAreversinPharmaselect International Beteiligungs Gmbh
- CzechiaBLOVOVANVianex S.A., Nea Erythrea
- CzechiaBLOVOVANVianex S.A., Nea Erythrea
- PolandBridionMerck Sharp & Dohme B.V.
- FinlandBridionMerck Sharp & Dohme B.V.
- IcelandBridionMerck Sharp & Dohme B.V.*
- United StatesBRIDIONMerck Sharp & Dohme LLC
- United StatesBRIDIONMerck Sharp & Dohme LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f8feff3-8726-4161-9d7d-3bf5340c51a8 GET /v1/drugs/5f8feff3-8726-4161-9d7d-3bf5340c51a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28104188807",
"substance": "Sugammadexnatrium",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "39654"
}See everything about sugammadex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.